Dr. Samuel P Fortin, Ph.D
Claim this profileClinical Trials Samuel P Fortin, Ph.D is currently running
More about Samuel P Fortin, Ph.D
Clinical Trial Related
2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Samuel P Fortin, Ph.D has experience with
- Omega-3 Monoglyceride Based Topic Products
Breakdown of trials Samuel P Fortin, Ph.D has run
Dermatitis
Medical Device Dermatitis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Samuel P Fortin, Ph.D specialize in?
Samuel P Fortin, Ph.D focuses on Dermatitis and Medical Device Dermatitis. In particular, much of their work with Dermatitis has involved treating patients, or patients who are undergoing treatment.
Is Samuel P Fortin, Ph.D currently recruiting for clinical trials?
Yes, Samuel P Fortin, Ph.D is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Samuel P Fortin, Ph.D has studied deeply?
Yes, Samuel P Fortin, Ph.D has studied treatments such as Omega-3 Monoglyceride Based Topic Products.
What is the best way to schedule an appointment with Samuel P Fortin, Ph.D?
Apply for one of the trials that Samuel P Fortin, Ph.D is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.